New York, May 22, 2026, 11:08 EDT
GridAI Technologies Corp. slid 7.8% to $4.25 by late morning Friday, setting a new session low. Traders are weighing a new debt settlement and the possibility of more shares, adding pressure to the Nasdaq stock. GridAI opened at $4.47. Volume was 49,530 at 11:00 a.m. EDT, market cap stood at $26.35 million, according to Google Finance.
GridAI is working to clean up its balance sheet. The company said in a May 20 Form 8-K that it settled a default on its revolving loan with an $800,000 payment—$700,000 for principal, $100,000 in accrued interest. It’s also giving the lender 71,482 common shares at $3.25 each to cover another $232,315 in interest. The lender had sought $1.014 million after the loan matured Jan. 31 and wasn’t repaid.
GridAI’s settlement follows a broader financing move. In a filing last week, GridAI said it raised about $7.79 million in gross proceeds through private placements, issuing common stock, pre-funded warrants and common stock purchase warrants to certain investors instead of going public. Pre-funded warrants let investors buy shares later after paying most of the price up front. The firm said the money will be used for working capital and to pay down some liabilities.
Dilution looks simple in this case. If warrants get exercised and new shares hit the market, current holders own less unless the business expands fast. Low volume means even a small batch of new shares can weigh on the price.
GridAI flagged regulatory timing as an issue Wednesday. It filed a notice May 15 saying it couldn’t get its quarterly report for the period ended March 31 in on time without unreasonable effort or cost. The delay comes as the company is still finalizing its 2025 annual report. Interim CFO Anna Skowron signed off on the filing.
GridAI had another Nasdaq matter before this. The company said in a May 5 filing that it got word from Nasdaq on May 4 it was back in compliance, after turning in its 2025 Form 10-K on May 1.
GridAI reported 2025 revenue of just $36,251 and a net loss of $6.55 million. Cash and equivalents ended at $899,784, with total accumulated deficit at about $208.8 million. Management warned of “substantial doubt” over GridAI’s ability to keep going unless it raises more capital. The company’s AI data-center platform remains early stage and is not yet commercial. SEC
GridAI, formerly Entero Therapeutics, describes itself as a grid-edge AI platform that manages power loads and distributed energy resources such as batteries. The company still keeps legacy gastrointestinal drug development assets. Shares fell, even as the S&P 500, Nasdaq Composite and Dow traded higher, Reuters market data showed.
GridAI works at the edge where energy and software connect. The company is still early and hasn’t rolled out commercially yet. Eos Energy Enterprises and Stem are public players in a similar area. Eos uses zinc for its energy storage tech, while Stem offers AI-powered clean energy software and services. But the point here is market focus, not how much money they make or their size.
GridAI executives are pitching their plan to meet energy demand from AI data centers. In December, GridAI CEO Jason Sawyer called hyperscale AI campuses “the defining infrastructure challenge.” Marshall Chapin, who heads GridAI’s operating arm, said, “AI data centers are reshaping the grid.” ACCESS Newswire
Filings might keep moving the stock more than any news about customers. If the quarterly report gets held up again, financing remains tough and adds more shares, or if development to paid users drags out, Friday’s drop might keep going. But if that debt agreement holds and investors see some better liquidity, then it’s just a matter of the company building from here.
